1. Targeting Tn-positive tumors with an afucosylated recombinant anti-Tn IgG
   Yasuyuki Matsumoto et al, 2023, Scientific Reports CrossRef
2. Vandetanib-eluting radiopaque beads for chemoembolization: physicochemical evaluation and biological activity of vandetanib in hypoxia
   Alice E. Hagan et al, 2021, Anti-Cancer Drugs CrossRef
3. Intra- and inter-patient diversity in hepatocellular carcinoma based on phosphorylation profiles—A pilot study in a single institution
   Kan Toriguchi et al, 2024, Clinics and Research in Hepatology and Gastroenterology CrossRef
4. Purification and characterization of the extracellular region of human receptor tyrosine kinase like orphan receptor 2 (ROR2)
   Yuan Li et al, 2019, Protein Expression and Purification CrossRef
5. Ephrin–Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies
   Sowmya Mekala et al, 2023, Journal of Cell Communication and Signaling CrossRef
6. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
   Min Zhang et al, 2016, Oncotarget CrossRef
7. Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions
   Daoqi Zhu et al, 2017, Oncology Letters CrossRef
8. Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays
   TAKAKO NOMURA et al, 2013, Oncology Reports CrossRef
9. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder
   Zheng-Chun Wu et al, 2017, World Journal of Gastroenterology CrossRef